National Debate on Drugs
In 2011, various civil society and government organizations, health professionals, political representatives, students, national and international experts, all met to discuss the development of public policies and a public agenda on drug regulation. This dialogue emerged as a result of the need to address the issue from a human rights perspective, of and the lack of sound and efficient public policies. The three-day debate consisted of conferences, panels, workshops, and working sessions. The objective of the debate was to produce a document, the result of the debate between the diverse participants involved, with the principles and strategies that are key to the design of a national drug policy.
Institutional design
Formalization: is the innovation embedded in the constitution or legislation, in an administrative act, or not formalized at all?
Frequency: how often does the innovation take place: only once, sporadically, or is it permanent or regular?
Mode of Selection of Participants: is the innovation open to all participants, access is restricted to some kind of condition, or both methods apply?
Type of participants: those who participate are individual citizens, civil society organizations, private stakeholders or a combination of those?
Decisiveness: does the innovation takes binding, non-binding or no decision at all?
Co-governance: is there involvement of the government in the process or not?
- Formalization
- not backed by constitution nor legislation, nor by any governmental policy or program
- Frequency
- single
- Mode of selection of participants
- both
- Type of participants
- citizens civil society
- Decisiveness
- democratic innovation yields no decision
- Co-Governance
- no
Means
|
Ends
|
